Volume 31, supplement 4, September 2024

ÉDITORIAL

Advances in pancreatic cancer (p.5-7)
Pascal Hammel

MINI-REVUES

Epidemiological, treatment modalities and survival trends in pancreatic cancer. PAPRICAP study (p.9-13)
Léo Mas, Jean-Baptiste Bachet

Tissue and blood molecular markers (p.14-7)
Jérôme Cros, Rémy Nicolle, Nelson Dusetti
Free Access

New developments in endoscopic ultrasound (p.18-22)
Christophe Bellanger, Bertrand Napoléon, Laurent Palazzo

New developments in pancreatic cancer surgery (p.24-30)
Andrea Peloso, Gabriella Pittau, Antonio Sa Cunha

Updates in neoadjuvant treatment of pancreatic cancer (p.31-7)
Nicolas Williet, Louis de Mestier, Brice Chanez

Adjuvant treatment of pancreatic cancer: Towards new perspectives in 2024 (p.38-46)
Daniel Pietrasz, Anthony Turpin, Thierry Conroy, Pascal Hammel

Locally advanced pancreatic cancer (p.48-54)
Fabienne Portales, Alice Boilève, Morgan Michalet, Michel Ducreux

Metastatic pancreatic adenocarcinoma in 2024 (p.55-63)
Brice Chanez, Christelle de la Fouchardière, Emmanuel Mitry

Post-operative oligometastatic recurrence (p.64-71)
Anthony Turpin, Sara El Kurdi, Pauline Parent, Victoria Pacquement, Stéphanie Truant, Pascal Hammel

Physical activity and nutritional management in pancreatic cancer: a treatment in its own right! (p.73-80)
Eva Ester Molina Beltran, Clémence Trihan, Cindy Neuzillet

The psychological impact of pancreatic cancer: essential supportive care! (p.81-4)
Anthony Turpin, Virginia Nicolaidis, Cécile Flahault, Aurélie Untas, Pascal Hammel